Introduction Indium-ill labelled autologous leucocyte imaging is now an established method for locating infection, both within the abdomen and at other sites.' -3 Recent reports suggest that it also accurately assesses the extent of colonic inflammatory bowel disease.' I To date there is only one report of its use in acute pancreatitis-namely, in patients being investigated for suspected pancreatic abscesses. 6 We report our experience of the use of "'In imaging in patients with acute pancreatitis.
Patients and methods
Thirteen patients were studied prospectively. Seven were women and six men, and their average age was 56 years (range 19-86). The diagnosis of acute pancreatitis was based on the clinical presentation together with a serum amylase activity greater than 1000 IU/I (mean value on admission 3257 IU/I, range 1050-8100 IU/1). Serum amylase measurements were recorded daily until they had returned to normal, and thereafter they were recorded every three days until discharge. In four patients the serum amylase activity had returned to normal three days after admission, in three patients by the fourth day, in a further four patients by day 5, and in the final two patients by day 7.
The severity of the initial attack was assessed using the prognostic factor grading system described by Imrie et a1,7 as modified for gall stone associated pancreatitis.8 Two patients developed hypocalcaemia, with serum calcium concentrations falling below 2 0 mmol/l (8 0 mg/ 100 ml). Ultrasound examinations were performed in 11 of the patients within five days of admission.
For each patient autologous leucocytes labelled with "'In were prepared using "'In-hydroxyquinoline (oxine) solution (Amersham International IN 15P), the labelling dose being in the range [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] MBq (270-540 1iCi). A mean labelling efficiency of 78.50% (range 62-95") was achieved for all patients studied. In all cases at least one set of images was obtained within 24 hours of administration of the labelled leucocytes. Imaging was performed with the patients supine using a large field of view gammacamera fitted with a parallel hole medium energy collimator and with analyser windows set to accept the 171 and 247 keV gamma photons from I"'In. At least 400 000 counts per image were collected. Imaging was performed within three days of admission in 12 patients and on day 7 after diagnosis in the remaining patient.
Results
The table shows the aetiology and severity of the condition in the 13 patients and compares the results of "'In-leucocyte imaging and abdominal ultrasound. Three patients had severe pancreatitis, and all three had positive "'In-leucocyte imaging results (fig 1) . A fourth patient (case 8), judged on prognostic factors to have mild disease, had a positive result on "'In-leucocyte imaging (fig 2) . This patient developed a pseudocyst 14 days after admission.
The remaining nine patients all had mild pancreatitis on prognostic What does a positive "'In imaging result mean? In case 13 computed tomography was carried out 24 hours after radionuclide imaging and showed the presence of extensive fat necrosis in areas corresponding to those showing increased leucocyte uptake on the indium image. Extensive fat necrosis was also noted in cases 8 and 10 at subsequent cholecystectomy. We believe that a positive "'In imaging result implies severe fat necrosis.
From our initial experience it seems that "'In-leucocyte imaging is a simple, noninvasive technique for assessing severity early in the course of acute pancreatitis. Its accuracy is similar to that of prognostic factor grading. Further studies using serial imaging are needed to define more precisely the fate of fat necrosis in acute pancreatitis.
